These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2748526)

  • 21. Target-mediated drug disposition and dynamics.
    Mager DE
    Biochem Pharmacol; 2006 Jun; 72(1):1-10. PubMed ID: 16469301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
    Besunder JB; Reed MD; Blumer JL
    Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of drug distribution and drug-target binding on target occupancy: The rate-limiting step approximation.
    de Witte WEA; Vauquelin G; van der Graaf PH; de Lange ECM
    Eur J Pharm Sci; 2017 Nov; 109S():S83-S89. PubMed ID: 28502676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of cardiac output distribution on the tissue/plasma drug concentration ratio.
    Fagiolino P
    Eur J Drug Metab Pharmacokinet; 2002; 27(2):79-81. PubMed ID: 12064375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A probabilistic approach to the single-point, single-dose problem.
    Briggs WL; Phelps RW; Swanson GD
    IEEE Trans Biomed Eng; 1990 Jan; 37(1):80-4. PubMed ID: 2303274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).
    Chiou WL
    Clin Pharmacokinet; 1989 Sep; 17(3):175-99. PubMed ID: 2680213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of infusion rates: computer study.
    Harrison MJ
    Br J Anaesth; 1990 Mar; 64(3):283-6. PubMed ID: 2328176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tanshinone IIA - loaded pellets developed for angina chronotherapy: Deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation.
    Yan HX; Li J; Li ZH; Zhang WL; Liu JP
    Eur J Pharm Sci; 2015 Aug; 76():156-64. PubMed ID: 25976225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple model to solve a complex drug toxicity problem.
    Dixit VA
    Toxicol Res (Camb); 2019 Mar; 8(2):157-171. PubMed ID: 30997019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model-independent steady-state plasma level predictions in autonomic nonlinear pharmacokinetics I: Derivation and theoretical analysis.
    Veng-Pedersen P
    J Pharm Sci; 1984 Jun; 73(6):761-5. PubMed ID: 6737260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application.
    Minto CF; Schnider TW; Shafer SL
    Anesthesiology; 1997 Jan; 86(1):24-33. PubMed ID: 9009936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
    Poulin P; Burczynski FJ; Haddad S
    J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target mediated drug disposition with drug-drug interaction, Part II: competitive and uncompetitive cases.
    Koch G; Jusko WJ; Schropp J
    J Pharmacokinet Pharmacodyn; 2017 Feb; 44(1):27-42. PubMed ID: 28074396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
    Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
    Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The method of relative drug accumulation: a simple method for illustrating the effects of different drug dosing regimens and variability in drug elimination on time courses of drug concentrations.
    Bjornsson TD
    Clin Pharmacol Ther; 1992 Mar; 51(3):266-70. PubMed ID: 1544286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated pharmacokinetics and pharmacodynamics in drug development.
    Dingemanse J; Appel-Dingemanse S
    Clin Pharmacokinet; 2007; 46(9):713-37. PubMed ID: 17713971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.